Did you know that 38.4 million people worldwide suffer from diabetes? The growing demand for effective diabetes prevention and management drives companies to develop innovative products, supplements for diabetes, and solutions.
According to Extrapolate, the global diabetes supplements market is estimated to accrue a valuation of $29.16 billion in 2030. This is a massive up from $14.12 billion in 2022. This blog post discusses the top 10 companies involved in this sector, bifurcated based on their global presence.
What are Diabetes Supplements?
Diabetes supplements refer to various vitamins, minerals, herbs, and other nutritional products that some individuals with diabetes may use to help manage their condition. While these supplements are often marketed as beneficial for blood sugar control or overall health, it's essential to approach them cautiously.
How Safe Are Dietary Supplements For Diabetes?
Some dietary supplements may pose risks, including serious side effects like kidney damage. The U.S. Food and Drug Administration (FDA) has issued warnings about certain diabetes products that make dubious claims, such as being a “natural cure for diabetes” or able to “replace your diabetes medication.” These products are often marketed illegally and can be harmful on their own, especially when used instead of proven diabetes treatments. It is crucial not to substitute medical diabetes treatments with unverified health products or practices.
Top 10 Diabetes Supplements Companies Transforming Metabolic Health
1. Abbott
Abbott is a global healthcare company with a significant presence in the dietary supplements sector, offering products that support general wellness and specialized nutritional needs. Their supplement range includes vitamins, minerals, and other nutritional products aimed at improving health outcomes.
In July 2024, Abbott introduced GLUCERNA 1.5 CAL, a unique mix of low-glycemic and slowly digestible carbohydrates, curated to help reduce blood glucose response compared to high-glycemic carbohydrates.
2. AKSUVITAL Natural Products Food Co.
AksuVital is a brand known for its range of health supplements, including products specifically designed to aid individuals with diabetes. The company emphasizes natural ingredients and herbal formulations aimed at supporting metabolic health and regulating blood sugar levels.
3. Arkopharma
Arkopharma is a well-established French company specializing in the development of dietary supplements, particularly those derived from natural sources. With a strong emphasis on phytotherapy, Arkopharma aims to integrate the benefits of plant-based ingredients into health solutions, including those for managing diabetes.
4. Bionova
Bionova is a pharmaceutical company that focuses on developing and manufacturing dietary supplements, including those aimed at supporting individuals with diabetes. The company is committed to quality and innovation, striving to provide effective health solutions that cater to various therapeutic needs.
5. Nestlé
Nestlé, a global leader in nutrition, health, and wellness, has made significant strides in the development of dietary supplements specifically designed for individuals managing diabetes. Through its Nestlé Health Science division, the company offers a range of products aimed at supporting blood sugar control and overall nutritional health for people with diabetes.
Nestle launched Nutren Diabetes, a balanced blend of nutrients designed for individuals who are worried about their blood sugar levels.
6. Caelus Health
Amsterdam-based biotech company Caelus Health is dedicated to the commercialization and development of diabetes and products to prevent and treat cardiometabolic disorders.
The company has established a robust patented-protected unique position in the treatment of auto-immune illnesses, diabetes mellitus Type 2 and Type 1, and cancer cachexia.
7. Danone
Danone is a multinational food-products corporation known for its commitment to health and wellness, particularly through dairy and plant-based products. While Danone primarily focuses on consumer health products and nutrition, it has also ventured into specialized nutrition, including products aimed at individuals with diabetes.
8. Novo Nordisk A/S
Novo Nordisk A/S is a prominent global healthcare company headquartered in Denmark, founded in 1923. The company is particularly well-known for its extensive work in diabetes care, focusing on the discovery, development, manufacturing, and marketing of pharmaceutical products aimed at managing diabetes and other serious chronic diseases.
In 2021, the U.S. Food and Drug Administration approved Ozempic, a drug made by Novo Nordisk, as a diabetes medication; the agency approved Wegovy in 2021. This led to a massive 45% ($5.7 billion) surge in profit in Q1 of 2021 due to the increased demand for the drugs.
9. Pfizer Inc.
Pfizer Inc. is a leading global pharmaceutical company headquartered in New York City, known for its extensive portfolio of medications across various therapeutic areas, including diabetes care. The company has made significant contributions to diabetes management through the development of innovative treatments and ongoing research.
In 2024, Pfizer demonstrated that its diabetes drug, danuglipron, has significant weight loss effects in a recent study, positioning it as a strong competitor to Novo Nordisk's widely-used Ozempic. This development marks a crucial step for Pfizer in expanding its presence in the lucrative diabetes and obesity drug market.
10. Unilever
Unilever is a multinational consumer goods company known for its diverse range of products in nutrition, hygiene, and personal care. While Unilever is not primarily recognized as a pharmaceutical company, it has made significant contributions to health and nutrition, including products that can support individuals managing diabetes.
Conclusion
The landscape of diabetes management is continually evolving, driven by the innovative efforts of pharmaceutical companies that have developed a diverse array of treatment options. These include insulin therapies, oral antidiabetic medications, GLP-1 receptor agonists, and SGLT2 inhibitors, each playing a crucial role in helping patients manage their blood glucose levels effectively.
As research progresses, new therapies are emerging, offering hope for improved outcomes and quality of life for those living with diabetes. However, patients need to engage in personalized treatment discussions with their healthcare providers, ensuring that choices are tailored to their unique medical histories and needs. This collaborative approach enhances treatment efficacy and empowers patients in their journey toward better health.
